D
Douglass A. Morrison
Researcher at University of Arizona
Publications - 32
Citations - 3506
Douglass A. Morrison is an academic researcher from University of Arizona. The author has contributed to research in topics: Percutaneous coronary intervention & Angioplasty. The author has an hindex of 16, co-authored 32 publications receiving 3447 citations. Previous affiliations of Douglass A. Morrison include Veterans Health Administration & Anschutz Medical Campus.
Papers
More filters
Journal ArticleDOI
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-summary article : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)
Sidney C. Smith,Ted Feldman,John W. Hirshfeld,Alice K. Jacobs,Morton J. Kern,Spencer B. King,Douglass A. Morrison,William W. O'Neill,Hartzell V. Schaff,Patrick L. Whitlow,David O. Williams,Elliott M. Antman,Cynthia D. Adams,Jeffrey L. Anderson,David P. Faxon,Valentin Fuster,Jonathan L. Halperin,Loren F. Hiratzka,Sharon A. Hunt,Rick A. Nishimura,Joseph P. Ornato,Richard L. Page,Barbara Riegel +22 more
TL;DR: The American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions (ACC/AHA/SCAI) 2005 Guideline Update for Percutaneous Coronary Intervention (PCI) contains changes in the recommendations, along with supporting text.
Journal ArticleDOI
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery for Patients With Medically Refractory Myocardial Ischemia and Risk Factors for Adverse Outcomes With Bypass: A Multicenter, Randomized Trial
Douglass A. Morrison,Gulshan K. Sethi,Jerome Sacks,William G. Henderson,Frederick L. Grover,Steven P. Sedlis,Rick A. Esposito,Kodangudi B. Ramanathan,Darryl Weiman,Jorge Saucedo,Tamim Antakli,Venki Paramesh,Stuart Pett,Sarah Vernon,Vladimir Birjiniuk,Frederick G.P. Welt,Mitchell W. Krucoff,Walter G. Wolfe,John C. Lucke,Sundeep Mediratta,David C. Booth,Charles Barbiere,Daniel W. Lewis +22 more
TL;DR: In this article, a five-year, multicenter, randomized clinical trial was designed to compare long-term survival among patients with medically refractory myocardial ischemia and a high risk of adverse outcomes assigned to either a CABG or a PCI strategy, which could include stents.
Journal ArticleDOI
Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients.
Douglass A. Morrison,Gulshan K. Sethi,Jerome Sacks,William G. Henderson,Frederick L. Grover,Steven P. Sedlis,Rick A. Esposito +6 more
TL;DR: The AWESOME randomized trial as discussed by the authors compared long-term percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) survival among post CABG patients included in the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) randomized trial and prospective registry.
Journal ArticleDOI
Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry
Steven P. Sedlis,Douglass A. Morrison,Jeffrey D. Lorin,Rick A. Esposito,Gulshan K. Sethi,Jerome Sacks,William G. Henderson,Frederick L. Grover,Kodangudi Ramanathan,Darryl Weiman,Jorge Saucedo,Tamim Antakli,Venki Paramesh,Stuart Pett,Sarah Vernon,Vladimir Birjiniuk,Frederick G.P. Welt,Mitchell W. Krucoff,Walter G. Wolfe,John C. Lucke,Sundeep Mediratta,David C. Booth,Edward Murphy,Herbert B. Ward,La Wayne Miller,Stefan Kiesz,Charles Barbiere,Daniel W. Lewis +27 more
TL;DR: It is concluded that PCI is a relatively safe alternative to CABG for diabetic patients with medically refractory unstable angina who are at high risk for CABGs.
Journal ArticleDOI
Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia.
John S. Rumsfeld,John S. Rumsfeld,David J. Magid,Mary E. Plomondon,Jerome Sacks,William G. Henderson,Mark A. Hlatky,Gulshan K. Sethi,Douglass A. Morrison +8 more
TL;DR: High-risk patients with medically refractory ischemia randomized to PCI versus CABG surgery have equivalent six-month health-related quality of life (HRQL), and HRQL concerns should not drive decision-making regarding selection of a revascularization procedure for these patients.